These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18056177

  • 1. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
    Cillessen SA, Hess CJ, Hooijberg E, Castricum KC, Kortman P, Denkers F, Vos W, van de Wiel MA, Schuurhuis GJ, Ossenkoppele GJ, Meijer CJ, Oudejans JJ.
    Clin Cancer Res; 2007 Dec 01; 13(23):7012-21. PubMed ID: 18056177
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
    Muris JJ, Ylstra B, Cillessen SA, Ossenkoppele GJ, Kluin-Nelemans JC, Eijk PP, Nota B, Tijssen M, de Boer WP, van de Wiel M, van den Ijssel PR, Jansen P, de Bruin PC, van Krieken JH, Meijer GA, Meijer CJ, Oudejans JJ.
    Br J Haematol; 2007 Jan 01; 136(1):38-47. PubMed ID: 17062006
    [Abstract] [Full Text] [Related]

  • 5. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
    Oyarzo MP, Drakos E, Atwell C, Amin HM, Medeiros LJ, Rassidakis GZ.
    Hum Pathol; 2006 Jul 01; 37(7):874-82. PubMed ID: 16784988
    [Abstract] [Full Text] [Related]

  • 6. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
    Bavi P, Uddin S, Bu R, Ahmed M, Abubaker J, Balde V, Qadri Z, Ajarim D, Al-Dayel F, Hussain AR, Al-Kuraya KS.
    J Pathol; 2011 Jul 01; 224(3):355-66. PubMed ID: 21506127
    [Abstract] [Full Text] [Related]

  • 7. Molecular targeted therapies for diffuse large B-cell lymphoma based on apoptosis profiles.
    Cillessen SA, Meijer CJ, Notoya M, Ossenkoppele GJ, Oudejans JJ.
    J Pathol; 2010 Apr 01; 220(5):509-20. PubMed ID: 20087881
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma.
    Muris JJ, Meijer CJ, Ossenkoppele GJ, Vos W, Oudejans JJ.
    Hematol Oncol; 2006 Sep 01; 24(3):97-104. PubMed ID: 16715473
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).
    Markovic O, Marisavljevic D, Cemerikic V, Perunicic M, Savic S, Filipovic B, Mihaljevic B.
    Eur J Haematol; 2011 Mar 01; 86(3):246-55. PubMed ID: 21198858
    [Abstract] [Full Text] [Related]

  • 11. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
    Bai M, Skyrlas A, Agnantis NJ, Kamina S, Kitsoulis P, Kanavaros P.
    Anticancer Res; 2004 Mar 01; 24(5A):3081-8. PubMed ID: 15517919
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
    Mircean C, Tabus I, Kobayashi T, Yamaguchi M, Shiku H, Shmulevich I, Zhang W.
    Int J Oncol; 2004 Mar 01; 24(3):497-504. PubMed ID: 14767533
    [Abstract] [Full Text] [Related]

  • 18. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N, Ren Y, Rassidakis GZ, Schlette EJ, Medeiros LJ.
    Cancer; 2006 Oct 15; 107(8):1844-51. PubMed ID: 16983704
    [Abstract] [Full Text] [Related]

  • 19. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S, Zenz T, Schnaiter A, Mertens D, Winkler D, Döhner H, Debatin KM, Stilgenbauer S, Fulda S.
    Cancer Res; 2009 Dec 01; 69(23):8977-86. PubMed ID: 19920200
    [Abstract] [Full Text] [Related]

  • 20. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC, Muris JJ, Giroth CP, Vos W, Ossenkoppele GJ, Meijer CJ, Oudejans JJ.
    Histopathology; 2008 Apr 01; 52(5):578-84. PubMed ID: 18312353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.